Arrhythmogenic right ventricular dysplasia

Current Treatment Options in Cardiovascular Medicine

Volumn 12, Issue 6, 2010, Pages 598-613

  Patel, Harsh C ^b   Calkins, Hugh ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CADHERIN; DESMOCOLLIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLAKOGLOBIN; PLAKOPHILIN; SOTALOL;

AUTOSOMAL DOMINANT INHERITANCE; CLINICAL EVALUATION; DEFIBRILLATOR; DESMOSOME; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; ELECTROCARDIOGRAPHY; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; HEART DEATH; HEART DEPOLARIZATION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BIOPSY; HEART REPOLARIZATION; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE DYSPLASIA; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; IMMOBILIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIMARY PREVENTION; QRS COMPLEX; RADIOFREQUENCY ABLATION; REVIEW; RISK ASSESSMENT; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT INDICATION;

EID: 78649909066     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-010-0097-2     Document Type: Review

References (53)

1. F Marcus G Fontaine G Guiraudon, et al. 1982 Right ventricular dysplasia: a report of 24 adult cases Circulation 65 384 398 1:STN:280: DyaL38%2FptlOluw%3D%3D 7053899 (Pubitemid 12219036)
2. C Basso D Corrado G Thiene 1999 Cardiovascular causes of sudden death in young individuals including athletes Cardiol Rev 7 127 135 1:STN:280: DyaK1MzlsVWrug%3D%3D 10.1097/00045415-199905000-00009 10423663
3. S Peters M Trummel W Meyners 2004 Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital Int J Cardiol 97 499 501 10.1016/j.ijcard.2003.10.037 15561339 (Pubitemid 39550701)
4. F Marcus JA Towbin 2006 The mystery of arrhythmogenic right ventricular dysplasia/cardiomyopathy: from observation to mechanistic explanation Circulation 114 1794 1795 10.1161/CIRCULATIONAHA.106.653493 17060394 (Pubitemid 44673352)
5. D Dalal K Nasir C Bomma, et al. 2005 Arrhythmogenic right ventricular dysplasia: a United States Experience Circulation 112 3823 3832 10.1161/CIRCULATIONAHA.105.542266 16344387 (Pubitemid 43739479)
6. D Corrado C Basso G Thiene, et al. 1997 Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study J Am Coll Cardiol 30 1512 1520 1:STN:280: DyaK1c%2Fis1OgsQ%3D%3D 10.1016/S0735-1097(97)00332-X 9362410 (Pubitemid 27486470)
7. S Sen-Chowdhry MD Lowe SC Sporton, et al. 2004 Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management Am J Med 117 685 695 10.1016/j.amjmed.2004.04.028 15501207 (Pubitemid 40288176)
8. S Sen-Chowdhry P Syrris D Ward, et al. 2007 Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression Circulation 115 1710 1720 10.1161/CIRCULATIONAHA.106.660241 17372169 (Pubitemid 46648607)
9. D Dalal H Tandri D Judge, et al. 2009 Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy J Am Coll Cardiol 53 1289 1299 10.1016/j.jacc.2008.12.045 19358943 This genotype-MRI correlation study reported that in family members of ARVD probands, LV function is generally preserved and independent LV disease occurs rarely. It also showed the CMR features, such as the accordion sign, may be able to accurately detect early disease in affected family members.
10. C Basso G Thiene D Corrado, et al. 1996 Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation 94 983 991 1:STN:280:DyaK28zot1WksA%3D%3D 8790036
11. AP Burke A Farb G Tashko, et al. 1998 Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? Circulation 97 1571 1580 1:STN:280:DyaK1c3lsVeqtg%3D%3D 9593562
12. D Corrado G Fontaine FI Marcus, et al. 2000 Arrhythmogenic right ventricular dysplasia/cardiomyopathy. Need for an international registry Circulation 101 101 106
13. G McKoy N Protonotarios A Crosby, et al. 2000 Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease) Lancet 355 2119 2124 1:CAS:528:DC%2BD3cXkvVWjtrg%3D 10.1016/S0140-6736(00)02379-5 10902626
14. EE Norgett SJ Hatsell L Carvajal-Huerta, et al. 2000 Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma Hum Mol Genet 9 2761 2766 1:CAS:528:DC%2BD3cXosVKkur4%3D 10.1093/hmg/9.18.2761 11063735
15. A Rampazzo A Nava S Malacrida, et al. 2002 Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy Am J Hum Genet 71 1200 1206 1:CAS:528: DC%2BD38XovFOgu7k%3D 10.1086/344208 12373648 (Pubitemid 35305239)
16. K Pilichou A Nava C Basso, et al. 2006 Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy Circulation 113 1171 1179 1:CAS:528:DC%2BD28XhvVekt78%3D 10.1161/CIRCULATIONAHA.105.583674 16505173
17. G Beffagna M De Bortoli A Nava, et al. 2007 Missense mutations in desmocollin-2 N-terminus, associated with arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin-2 in vitro BMC Med Genet 8 65 10.1186/1471-2350-8-65 17963498
18. B Gerull A Heuser T Wichter, et al. 2004 Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy Nat Genet 36 1162 1164 1:CAS:528:DC%2BD2cXptVOhur4%3D 10.1038/ng1461 15489853 (Pubitemid 41288964)
19. G Beffagna G Occhi A Nava, et al. 2005 Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1 Cardiovasc Res 65 366 373 1:CAS:528:DC%2BD2MXitVamtA%3D%3D 10.1016/j.cardiores.2004.10.005 15639475 (Pubitemid 40082478)
20. N Tiso DA Stephan A Nava, et al. 2001 Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2) Hum Mol Genet 10 189 194 1:CAS:528:DC%2BD3MXht1Sktb8%3D 10.1093/hmg/10.3.189 11159936
21. ND Merner KA Hodgkinson AFM Haywood, et al. 2008 Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene Am J Hum Genet 82 1 13 10.1016/j.ajhg.2008.01.010 This article showed that mutation in a non-desmosomal protein is associated with a subtype of ARVD with prominent left ventricular disease.
22. A den Haan B Tan M Zikusoka, et al. 2009 Comprehensive desmosome mutation analysis in North Americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy Circ Cardiovasc Genet 2 428 435 10.1161/CIRCGENETICS. 109.858217 This was the first study to evaluate the prevalence and significance of desmosomal protein mutations in North Americans with known ARVD. It also highlighted that fact that despite recent advances in our understanding of the genetic basis of this disease, as many as 50% of ARVD patients still have no identifiable mutation.
23. N Protonotarios A Tsatsopoulou 2004 Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy Cardiovasc Pathol 13 185 194 1:CAS:528:DC%2BD2cXltVCqtbk%3D 10.1016/j.carpath.2004.03.609 15210133 (Pubitemid 38798357)
24. D Corrado C Basso G Rizzoli, et al. 2003 Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 42 1959 1963 10.1016/j.jacc.2003.03.002 14662259 (Pubitemid 37485572)
25. SR Kaplan JJ Gard N Protonotarios, et al. 2004 Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease) Heart Rhythm 1 3 11 10.1016/j.hrthm.2004.01.001 15851108 (Pubitemid 38647241)
26. H Tandri A Asimaki D Dalal, et al. 2008 Gap junction remodeling in a case of arrhythmogenic right ventricular dysplasia due to plakoglobin-2 mutation J Cardiovasc Electrophysiol 11 1212 1214 10.1111/j.1540-8167.2008.01207.x
27. S Chen DC Guttridge Z You, et al. 2001 Wnt-1 signaling inhibits apoptosis by activating beta-Catenin/T cell factor-mediated transcription J Cell Biol 152 87 96 1:CAS:528:DC%2BD3MXjslyitw%3D%3D 10.1083/jcb.152.1.87 11149923 (Pubitemid 32102439)
28. E Garcia-Gras R Lombardi MJ Giocondo, et al. 2006 Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy J Clin Invest 116 2012 2021 1:CAS:528:DC%2BD28XmvV2lu74%3D 10.1172/JCI27751 16823493 (Pubitemid 44033325)
29. EK Wlodarska M Konka T Zaleska, et al. 2005 Arrhythmogenic right ventricular cardiomyopathy in two pairs of monozygotic twins Int J Cardiol 105 126 133 10.1016/j.ijcard.2004.11.016 16243102 (Pubitemid 41512477)
30. T Xu Z Yang M Vatta, et al. 2010 Compound and digenic hetrozygosity contributes to arrhythmogenic right ventricular cardiomyopathy J Am Coll Cardiol 55 587 597 1:CAS:528:DC%2BC3cXjt1Gmsrs%3D 10.1016/j.jacc.2009.11.020 20152563 This study showed that ARVD patients often display compound and digenic heterozygosity for desmosomal protein mutations. It provided support for the "second hit" hypothesis and showed that compound/digenic heterozygosity may be a potential mechanism of the variability in penetrance and expressivity of this disease. It also highlighted the complexity of using genetic analysis to diagnose ARVD.
31. NE Bowles J Ni F Marcus, et al. 2002 The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy J Am Coll Cardiol 39 892 895 10.1016/S0735-1097(02) 01688-1 11869858 (Pubitemid 34185340)
32. G Fontaine F Fontaliran JL Hebert, et al. 1999 Arrhythmogenic right ventricular dysplasia Annu Rev Med 50 17 35 1:CAS:528:DyaK1MXhsFyksr4%3D 10.1146/annurev.med.50.1.17 10073261 (Pubitemid 29117050)
33. MG Cox MR Nelen AA Wilde, et al. 2008 Activation delay and VT parameters in arrhythmogenic right ventricular dysplasia/cardiomyopathy: toward improvement of diagnostic ECG criteria J Cardiovasc Electrophysiol 19 775 781 10.1111/j.1540-8167.2008.01140.x 18373594 This study described a new ECG marker of right ventricular activation delay, called "terminal activation delay." It also demonstrated the low sensitivity of other forms of activation delay, such as parietal block and epsilon waves. (Pubitemid 352032791)
34. K Nasir C Bomma H Tandri, et al. 2004 Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria Circulation 110 1527 1534 10.1161/01.CIR.0000142293.60725.18 15381658 (Pubitemid 39297972)
35. F Marcus W McKenna D Sherrill, et al. 2010 Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria Circulation 121 1533 1541 10.1161/CIRCULATIONAHA.108.840827 20172911 This article provided a new model for the diagnosis of ARVD. It eliminated the subjectivity of many of the original Task Force criteria (such as for ventricular structure and function) by introducing validated imaging parameters. It also incorporated recently acquired knowledge and new technologies (such as CMR and genetic testing) to improve diagnostic sensitivity.
36. K Nasir J Rutberg H Tandri, et al. 2003 Utility of SAECG in arrhythmogenic right ventricle dysplasia Ann Noninvasive Electrocardiol 8 112 120 10.1046/j.1542-474X.2003.08204.x 12848791 (Pubitemid 38569991)
37. R Jain D Dalal A Daly, et al. 2009 Electrocardiographic features of arrhythmogenic right ventricular dysplasia Circulation 120 477 487 10.1161/CIRCULATIONAHA.108.838821 19635971 This study evaluated the sensitivity and specificity of some of the various ECG features of ARVD in the presence and absence of RBBB.
38. DM Yoerger F Marcus D Sherrill, et al. 2005 Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia J Am Coll Cardiol 45 860 865 10.1016/j.jacc.2004.10.070 15766820 (Pubitemid 40342810)
39. K Prakasa J Wang H Tandri, et al. 2007 Utility of Doppler and strain echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy Am J Cardiol 100 507 512 10.1016/j.amjcard.2007.03.053 17659937 (Pubitemid 47096824)
40. C Basso G Thiene 2005 Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat? Cardiovasc Pathol 14 37 41 10.1016/j.carpath.2004.12.001 15710290 (Pubitemid 40248431)
41. F Marcus W Zareba H Calkins, et al. 2009 Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: Results from the North American Multidisciplinary Study Heart Rhythm 6 984 992 10.1016/j.hrthm.2009.03.013 19560088 This study described the clinical profile of a large group of ARVD patients in North America. It reported the relative utility (including the sensitivity and specificity) of the various diagnostic tests used for the evaluation of ARVD patients. It also highlighted the complexities of diagnosing ARVD.
42. S Sen-Chowdhry SK Prasad P Syrris, et al. 2006 Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype J Am Coll Cardiol 48 2132 2140 10.1016/j.jacc.2006.07.045 17113003 (Pubitemid 44738443)
43. D Corrado C Basso L Leoni, et al. 2005 Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia Circulation 111 3042 3050 10.1161/CIRCULATIONAHA.104.486977 15939822 (Pubitemid 40847780)
44. A Asimaki H Tandri H Huang, et al. 2009 A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy N Engl J Med 360 1075 1084 1:CAS:528:DC%2BD1MXjtFyisL0%3D 10.1056/NEJMoa0808138 19279339 This study described a new diagnostic test for ARVD. It showed that immunohistochemical analysis of tissue specimens can provide high diagnostic sensitivity and specificity and improve the utility of endomyocardial biopsy.
45. W McKenna G Thiene A Nava, et al. 1994 Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology Br Heart J 71 215 218 1:STN:280:DyaK2c7ptVKrtg%3D%3D 10.1136/hrt.71.3.215 8142187
46. MS Hamid M Norman A Quraishi, et al. 2002 Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria J Am Coll Cardiol 40 1445 1450 10.1016/S0735-1097(02)02307-0 12392835 (Pubitemid 35192870)
47. D Corrado L Leoni M Link, et al. 2003 Implantable cardioverter- defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia Circulation 108 3084 3091 10.1161/01.CIR.0000103130.33451.D2 14638546 (Pubitemid 38031796)
48. JP Piccini D Dalal A Roguin, et al. 2005 Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia Heart Rhythm 2 1188 1194 10.1016/j.hrthm.2005.08.022 16253908 (Pubitemid 41614163)
49. T Wichter M Paul C Wollmann, et al. 2004 Implantable cardioverter/ defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients Circulation 109 1503 1508 10.1161/01.CIR.0000121738.88273.43 15007002 (Pubitemid 38420178)
50. D Dalal R Jain H Tandri, et al. 2007 Long term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy J Am Coll Cardiol 50 432 440 10.1016/j.jacc.2007.03.049 17662396 (Pubitemid 47088123)
51. Y Yao S Zhang D Sheng, et al. 2007 Radiofrequency ablation of the ventricular tachycardia with arrhythmogenic right ventricular cardiomyopathy using non-contact mapping Pacing Clin Electrophysiol 30 526 533 10.1111/j.1540-8159.2007.00703.x 17437577 (Pubitemid 46596130)
52. G Marcus D Glidden B Polonsky, et al. 2009 Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry J Am Coll Cardiol 54 609 615 1:CAS:528: DC%2BD1MXhtFaksbjI 10.1016/j.jacc.2009.04.052 19660690
53. S Sen-Chowdhry P Syrris WJ McKenna 2007 Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy J Am Coll Cardiol 50 1813 1821 1:CAS:528: DC%2BD2sXht1Glur%2FL 10.1016/j.jacc.2007.08.008 17980246 (Pubitemid 350007965)